Review



ecm deposition  (Santa Cruz Biotechnology)


Bioz Verified Symbol Santa Cruz Biotechnology is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 93
      Buy from Supplier

    Structured Review

    Santa Cruz Biotechnology ecm deposition
    (A) ASMC immunofluorescence staining for filamentous α-SMA, Igε-RI and Igε-RII. (B) Immune-blot of Igε-RI and Igε-RII siRNA treatment (48 hours) on protein expression; siCon: scrambled siRNA, U: untreated cells, GAPDH: house-keeping protein. <t>(C)</t> <t>IgE</t> induced <t>ECM.</t> (D) Collagen deposition (48 hours) and its modulation by siRNA targeting Igε-RI, Igε-RII or by Omalizumab. IgG served as control. Statistics: ANOVA. siCon: control siRNA; U: untreated cells.
    Ecm Deposition, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 28 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ecm+deposition/pmc03573085-57-11-27?v=Santa+Cruz+Biotechnology
    Average 93 stars, based on 28 article reviews
    ecm deposition - by Bioz Stars, 2026-07
    93/100 stars

    Images

    1) Product Images from "The Role of IgE-Receptors in IgE-Dependent Airway Smooth Muscle Cell Remodelling"

    Article Title: The Role of IgE-Receptors in IgE-Dependent Airway Smooth Muscle Cell Remodelling

    Journal: PLoS ONE

    doi: 10.1371/journal.pone.0056015

    (A) ASMC immunofluorescence staining for filamentous α-SMA, Igε-RI and Igε-RII. (B) Immune-blot of Igε-RI and Igε-RII siRNA treatment (48 hours) on protein expression; siCon: scrambled siRNA, U: untreated cells, GAPDH: house-keeping protein. (C) IgE induced ECM. (D) Collagen deposition (48 hours) and its modulation by siRNA targeting Igε-RI, Igε-RII or by Omalizumab. IgG served as control. Statistics: ANOVA. siCon: control siRNA; U: untreated cells.
    Figure Legend Snippet: (A) ASMC immunofluorescence staining for filamentous α-SMA, Igε-RI and Igε-RII. (B) Immune-blot of Igε-RI and Igε-RII siRNA treatment (48 hours) on protein expression; siCon: scrambled siRNA, U: untreated cells, GAPDH: house-keeping protein. (C) IgE induced ECM. (D) Collagen deposition (48 hours) and its modulation by siRNA targeting Igε-RI, Igε-RII or by Omalizumab. IgG served as control. Statistics: ANOVA. siCon: control siRNA; U: untreated cells.

    Techniques Used: Immunofluorescence, Staining, Expressing



    Similar Products

    ecm deposition  (Galectin Therapeutics)
    86
    Galectin Therapeutics ecm deposition
    Ecm Deposition, supplied by Galectin Therapeutics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ecm+deposition/pm42138208-274-11-0?v=Galectin+Therapeutics
    Average 86 stars, based on 1 article reviews
    ecm deposition - by Bioz Stars, 2026-07
    86/100 stars
    		  Buy from Supplier
    acellular ecm-deposited products, such as  (Humacyte Inc)
    90
    Humacyte Inc acellular ecm-deposited products, such as
    Acellular Ecm Deposited Products, Such As, supplied by Humacyte Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ecm+deposition/pm37177162-448-1-9?v=Humacyte+Inc
    Average 90 stars, based on 1 article reviews
    acellular ecm-deposited products, such as - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier
    ecm deposition  (Santa Cruz Biotechnology)
    93
    Santa Cruz Biotechnology ecm deposition
    (A) ASMC immunofluorescence staining for filamentous α-SMA, Igε-RI and Igε-RII. (B) Immune-blot of Igε-RI and Igε-RII siRNA treatment (48 hours) on protein expression; siCon: scrambled siRNA, U: untreated cells, GAPDH: house-keeping protein. <t>(C)</t> <t>IgE</t> induced <t>ECM.</t> (D) Collagen deposition (48 hours) and its modulation by siRNA targeting Igε-RI, Igε-RII or by Omalizumab. IgG served as control. Statistics: ANOVA. siCon: control siRNA; U: untreated cells.
    Ecm Deposition, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ecm+deposition/pmc03573085-57-11-27?v=Santa+Cruz+Biotechnology
    Average 93 stars, based on 1 article reviews
    ecm deposition - by Bioz Stars, 2026-07
    93/100 stars
    		  Buy from Supplier
    extracellular matrix (ecm) synthesis and deposition  (Millar Inc)
    90
    Millar Inc extracellular matrix (ecm) synthesis and deposition
    (A) ASMC immunofluorescence staining for filamentous α-SMA, Igε-RI and Igε-RII. (B) Immune-blot of Igε-RI and Igε-RII siRNA treatment (48 hours) on protein expression; siCon: scrambled siRNA, U: untreated cells, GAPDH: house-keeping protein. <t>(C)</t> <t>IgE</t> induced <t>ECM.</t> (D) Collagen deposition (48 hours) and its modulation by siRNA targeting Igε-RI, Igε-RII or by Omalizumab. IgG served as control. Statistics: ANOVA. siCon: control siRNA; U: untreated cells.
    Extracellular Matrix (Ecm) Synthesis And Deposition, supplied by Millar Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ecm+deposition/pm36994416-32-9-28?v=Millar+Inc
    Average 90 stars, based on 1 article reviews
    extracellular matrix (ecm) synthesis and deposition - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier
    ecm deposition assay anti collagen  (Novus Biologicals)
    96
    Novus Biologicals ecm deposition assay anti collagen
    (A) ASMC immunofluorescence staining for filamentous α-SMA, Igε-RI and Igε-RII. (B) Immune-blot of Igε-RI and Igε-RII siRNA treatment (48 hours) on protein expression; siCon: scrambled siRNA, U: untreated cells, GAPDH: house-keeping protein. <t>(C)</t> <t>IgE</t> induced <t>ECM.</t> (D) Collagen deposition (48 hours) and its modulation by siRNA targeting Igε-RI, Igε-RII or by Omalizumab. IgG served as control. Statistics: ANOVA. siCon: control siRNA; U: untreated cells.
    Ecm Deposition Assay Anti Collagen, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ecm+deposition/pmc09314350__41467_2022_31890_MOESM2_ESM-20-0-6?v=Novus+Biologicals
    Average 96 stars, based on 1 article reviews
    ecm deposition assay anti collagen - by Bioz Stars, 2026-07
    96/100 stars
    		  Buy from Supplier
    human cadaveric smc-deposited ecm  (Humacyte Inc)
    90
    Humacyte Inc human cadaveric smc-deposited ecm
    Summary of TEVG studies that involved clinical trials and large animal models
    Human Cadaveric Smc Deposited Ecm, supplied by Humacyte Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ecm+deposition/pmc11468936-3-0-54?v=Humacyte+Inc
    Average 90 stars, based on 1 article reviews
    human cadaveric smc-deposited ecm - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier
    human smc‑deposited ecm  (Humacyte Inc)
    90
    Humacyte Inc human smc‑deposited ecm
    Summary of TEVG studies that involved clinical trials and large animal models
    Human Smc‑Deposited Ecm, supplied by Humacyte Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ecm+deposition/pmc11468936-2-0-28?v=Humacyte+Inc
    Average 90 stars, based on 1 article reviews
    human smc‑deposited ecm - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier
    allogeneic canine smc‐deposited ecm  (Humacyte Inc)
    90
    Humacyte Inc allogeneic canine smc‐deposited ecm
    Summary of TEVG studies that involved clinical trials and large animal models
    Allogeneic Canine Smc‐Deposited Ecm, supplied by Humacyte Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ecm+deposition/pmc11468936-4-0-46?v=Humacyte+Inc
    Average 90 stars, based on 1 article reviews
    allogeneic canine smc‐deposited ecm - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier
    extracellular matrix ecm deposition  (Santa Cruz Biotechnology)
    93
    Santa Cruz Biotechnology extracellular matrix ecm deposition
    Summary of TEVG studies that involved clinical trials and large animal models
    Extracellular Matrix Ecm Deposition, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ecm+deposition/pmc07952450-66-5-30?v=Santa+Cruz+Biotechnology
    Average 93 stars, based on 1 article reviews
    extracellular matrix ecm deposition - by Bioz Stars, 2026-07
    93/100 stars
    		  Buy from Supplier

    Image Search Results


    (A) ASMC immunofluorescence staining for filamentous α-SMA, Igε-RI and Igε-RII. (B) Immune-blot of Igε-RI and Igε-RII siRNA treatment (48 hours) on protein expression; siCon: scrambled siRNA, U: untreated cells, GAPDH: house-keeping protein. (C) IgE induced ECM. (D) Collagen deposition (48 hours) and its modulation by siRNA targeting Igε-RI, Igε-RII or by Omalizumab. IgG served as control. Statistics: ANOVA. siCon: control siRNA; U: untreated cells.

    Journal: PLoS ONE

    Article Title: The Role of IgE-Receptors in IgE-Dependent Airway Smooth Muscle Cell Remodelling

    doi: 10.1371/journal.pone.0056015

    Figure Lengend Snippet: (A) ASMC immunofluorescence staining for filamentous α-SMA, Igε-RI and Igε-RII. (B) Immune-blot of Igε-RI and Igε-RII siRNA treatment (48 hours) on protein expression; siCon: scrambled siRNA, U: untreated cells, GAPDH: house-keeping protein. (C) IgE induced ECM. (D) Collagen deposition (48 hours) and its modulation by siRNA targeting Igε-RI, Igε-RII or by Omalizumab. IgG served as control. Statistics: ANOVA. siCon: control siRNA; U: untreated cells.

    Article Snippet: To study the role of the two IgE receptors on IgE-induced ECM deposition, cells were pre-treated with 0, 1, or 5 µM of IgE receptor specific siRNAs (Santa Cruz Biotech) for 24 hours.

    Techniques: Immunofluorescence, Staining, Expressing

    Summary of TEVG studies that involved clinical trials and large animal models

    Journal: Advanced Healthcare Materials

    Article Title: Immunomodulation Strategies for the Successful Regeneration of a Tissue‐Engineered Vascular Graft

    doi: 10.1002/adhm.202200045

    Figure Lengend Snippet: Summary of TEVG studies that involved clinical trials and large animal models

    Article Snippet: Human cadaveric SMC‐deposited ECM , Cell deposition and decellularization , 6 , Decellularized , In vivo (baboon model, arteriovenous access) , Patent for up to 6 months Patency rate was 88% No dilation and change in thickness for 24 weeks No sign of infection, calcification, aneurysmal dilation, and no substantial intimal hyperplasia , Niklason Lab/Humacyte , Dahl et al., 2011.

    Techniques: Clinical Proteomics, In Vivo, Infection

    Summary of TEVG studies that involved clinical trials and large animal models

    Journal: Advanced Healthcare Materials

    Article Title: Immunomodulation Strategies for the Successful Regeneration of a Tissue‐Engineered Vascular Graft

    doi: 10.1002/adhm.202200045

    Figure Lengend Snippet: Summary of TEVG studies that involved clinical trials and large animal models

    Article Snippet: Human SMC‐deposited ECM , Cell deposition and decellularization , 6 , Decellularized , Phase 2 Clinical trial as arteriovenous access and ongoing Phase 3 trial , , Niklason Lab/Humacyte , Kirkto et al., 2019.

    Techniques: Clinical Proteomics, In Vivo, Infection

    Summary of TEVG studies that involved clinical trials and large animal models

    Journal: Advanced Healthcare Materials

    Article Title: Immunomodulation Strategies for the Successful Regeneration of a Tissue‐Engineered Vascular Graft

    doi: 10.1002/adhm.202200045

    Figure Lengend Snippet: Summary of TEVG studies that involved clinical trials and large animal models

    Article Snippet: Allogeneic canine SMC‐deposited ECM , Cell deposition and decellularization , 3–4 , Autologous ECs , In vivo (canine carotid artery bypass graft) , Patency rate was 83% No sign of infection, calcification, aneurysmal dilation, and no intimal hyperplasia at anastomoses up to 1 year , Niklason Lab/Humacyte , Dahl et al., 2011.

    Techniques: Clinical Proteomics, In Vivo, Infection